links  Index Search   Modifiers   AMA Coding Clinic® for HCPCS   more

HCPCS Procedure & Supply Codes

Temporary Procedures & Professional Services

section notes

Quality Reporting Codes

section notes

Measure Groups for Quality Payment Program

section notes
G8633G9769   Measures 400-499
G9329G9763   Measures 300-399
G9497G9645   Measure 404: Anesthesiology Smoking Abstinence
G9511G9574   Measure 411: Depression Remission at Six Months
G9529G9533   Measure 415: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older
G9537G9537   Measure 419: Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological Examination
G9539G9544   Measure 421: Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal
G9552G9556   Measure 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients
G9561G9563   Measure 408: Opioid Therapy Follow-up Evaluation
G9577G9579   Measure 412: Documentation of Signed Opioid Treatment Agreement
G9580G9767   Measure 413: Door to Puncture Time for Endovascular Stroke Treatment
G9583G9685   Measure 414: Evaluation or Interview for Risk of Opioid Misuse
G9593G9597   Measure 416: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years
G9603G9605   Measure 420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey
G9606G9608   Measure 422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury
G9609G9611   Measure 423: Perioperative Anti-platelet Therapy for Patients Undergoing Carotid Endarterectomy
G9612G9614   Measure 425: Photodocumentation of Cecal Intubation
G9618G9774   Measure 429: Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy
G9621G9624   Measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
G9625G9627   Measure 432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair
G9628G9630   Measure 433: Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair
G9631G9633   Measure 434: Proportion of Patients Sustaining a Ureter Injury at the Time of any Pelvic Organ Prolapse Repair
G9634G9636   Measure 435: Quality of Life Assessment For Patients With Primary Headache Disorders
G9637G9638   Measure 436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques
G9639G9641   Measure 437: Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization Procedure
G9646G9648   Measure 409: Clinical Outcome Post Endovascular Stroke Treatment
G9649G9765   Measure 410: Psoriasis: Clinical Response to Oral Systemic or Biologic Medications
G9654G9773   Measure 424: Perioperative Temperature Management
G9655G9658   Measure 426: Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU)
G9659G9661   Measure 439: Age Appropriate Screening Colonoscopy
G9662G9783   Measure 438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
G9775G9777   Measure 430: Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy
G9784G9784   Measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time – Pathologist to Clinician
G9787G9797   Measure 441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)
G9805G9807   Measure 443: Non-Recommended Cervical Cancer Screening in Adolescent Females
G9808G9811   Measure 444: Medication Management for People with Asthma
G9812G9813   Measure 445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)
G9818G9821   Measure 447: Chlamydia Screening and Follow Up
G9822G9824   Measure 448: Appropriate Workup Prior to Endometrial Ablation
G9829G9837   Measure 450: Trastuzumab Received By Patients With AJCC Stage I (T1c) – III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy
G9838G9841   Measure 451: KRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
G9842G9845   Measure 452: Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies
G9846G9848   Measure 453: Proportion Receiving Chemotherapy in the Last 14 Days of Life
G9852G9854   Measure 455: Proportion Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life
G9858G9861   Measure 457: Proportion Admitted to Hospice for less than 3 days
G9943G9943   Measure 459: Average Change in Back Pain following Lumbar Discectomy / Laminotomy
G9946G9946   Measure 460: Average Change in Back Pain following Lumbar Fusion
G9954G9958   Measure 463: Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics)
G9959G9961   Measure 464: Otitis Media with Effusion (OME): Systemic Antimicrobials- Avoidance of Inappropriate Use
G9962G9963   Measure 465: "Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries"
G9964G9965   Measure 466: Well-child Visits
free demo
request yours today
for any budget
sign IN
welcome back!

Thank you for choosing Find-A-Code, please Sign In to remove ads.